Thanks to NASCAR champion and FOX Sports analyst, Jeff Gordon, and a grant from the Sohn Conference Foundation, a new program at MSK is hoping to support the identification of targeted therapies for children and provide access for the children who could benefit from these treatments. According to the organization, the Jeff Gordon & Sohn Precision Medicine Fund is “particularly important in the pediatric space because most cancer therapies are only approved for adult cancers, not childhood cancers or for use in children”, and the $200,000 grant is hoping to bring innovative treatments to these pediatric cancer patients.